RUBELLA VIRUS - ANVISA Registration 80638720216

Access comprehensive regulatory information for RUBELLA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80638720216 and manufactured by HANGZHOU ALLTEST BIOTECH CO., LTD. The registration is held by DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA - ME with validity until Jul 04, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.